J. Gy Papp

STEERING COMMITTEE AND INVESTIGATORS OF THE LEVOSIMENDAN INFUSION VERSUS DOBUTAMINE (LIDO) STUDY. EFFICACY AND SAFETY OF INTRAVENOUS LEVOSIMENDAN COMPARED WITH DOBUTAMINE IN SEVERE LOWOUTPUT HEART FAILURE (THE LIDO STUDY): A RANDOMISED DOUBLEBLIND TRIAL

Ferenc Folláth, John G.F. Cleland, H. Just et al. · 2002 · 159 citations

Medicine, Cardiology, Pharmacology +13

The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition.

Arun Chockalingam, I. BAlaguer-Vintro, Aloyzio Achutti et al. · PubMed · 2000 · 74 citations

Medicine, Cardiology, Preventive Medicine +17

Pharmacology of Levosimendan: A New Myofilament Calcium Sensitizer

Paul S. Pagel, Heimo Haikala, Pertti J. Pentikäinen et al. · Cardiovascular Drug Reviews · 1996 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +6

Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.

A. József Szentmiklósi, Miklós Németh, A Cseppentö et al. · PubMed · 1982 · 11 citations

Medicine, Pharmacology, Physiology +14